SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

BRIEF-Rocket Pharmaceuticals Posts Q1 Loss Per Share Of $0.65

05/10/2021 16:45
BRIEF-Rocket Pharmaceuticals Posts Q1 Loss Per Share Of $0.65

- Rocket Pharmaceuticals Inc RCKT.O:

  • ROCKET PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS

  • Q1 LOSS PER SHARE $0.65

  • Q1 EARNINGS PER SHARE ESTIMATE $-0.69 -- REFINITIV IBES DATA

  • ROCKET PHARMACEUTICALS - EXPECTS BALANCE IN CASH, CASH EQUIVALENTS, INVESTMENTS OF $466.4 MILLION AS OF MARCH 31, 2021 TO FUND OPERATIONS INTO H2 OF 2023

  • ROCKET PHARMACEUTICALS - RP-A501 PHASE 1 TRIAL FOR TREATMENT OF DANON DISEASE PLACED ON CLINICAL HOLD TO ADDRESS FDA REQUEST

  • ANTICIPATE DELAY IN ENROLLMENT IN RP-A501 PHASE 1 TRIAL BY ONE QUARTER

Source text for Eikon: ID:nBwbswB8ca

Further company coverage: RCKT.O


(([email protected];))